Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis

BACKGROUND: Characterization of the mesenchymal stromal cell (MSC) safety profile is important as this novel therapy continues to be evaluated in clinical trials for various inflammatory conditions. Due to an increase in published randomized controlled trials (RCTs) from 2012–2019, we performed an u...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EClinicalMedicine
Autors principals: Thompson, Mary, Mei, Shirley H.J., Wolfe, Dianna, Champagne, Josée, Fergusson, Dean, Stewart, Duncan J., Sullivan, Katrina J., Doxtator, Emily, Lalu, Manoj, English, Shane W., Granton, John, Hutton, Brian, Marshall, John, Maybee, Alies, Walley, Keith R., Santos, Claudia Dos, Winston, Brent, McIntyre, Lauralyn
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Research paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6970160/
https://ncbi.nlm.nih.gov/pubmed/31989101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.100249
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars